Page 103 - ஓஹியோ நிலை பல்கலைக்கழகம் வெக்ஸ்னர் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19 Apr 4, 2021 09:49 PM By Medical Daily Staff Last week Pfizer/BioNTech announced that its coronavirus vaccine will protect people for up to six months after the second dose. But it did lower its effectiveness level from 95% in November 2020, to 91%. That doesn’t surprise Carlos Malvestutto, MD, an infectious disease expert at The Ohio State University Wexner Medical Center. “Real world effectiveness is generally lower than clinical trial efficacy in most cases because clinical trial participants are a selected population of motivated individuals,” he explained. Dr. Malvestutto took the time to answer a few questions for Medical Daily. Q. Why would the results of a real-world study be so far off from those in a controlled trial, in which 10s of thousands of people were participating?

Moderna biontechCarlos malvestuttoOhio state university wexner medical centerOhio state university wexner medicalEmergency use authorizationCovid 19Clinical trialVaccine efficacyஓஹியோ நிலை பல்கலைக்கழகம் வெக்ஸ்னர் மருத்துவ மையம்ஓஹியோ நிலை பல்கலைக்கழகம் வெக்ஸ்னர் மருத்துவஅவசரம் பயன்பாடு அங்கீகாரம்மருத்துவ சோதனை